Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors, studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes. With an extended half-life of approximately 6 days, this peptide enables convenient once-weekly subcutaneous dosing with a gradual titration protocol to optimize tolerability.

• Reconstitute: Add 3.0 mL bacteriostatic water in cartridge at 20 clicks on the epipen will give you 2mg Reta and about 14-15 shots (weeks).
• Typical weekly range: 2–12 mg once weekly (gradual escalation over 12+ weeks).
• Easy measuring: At 10.0 mg/mL, 1 unit = 0.01 mL ≈ 100 mcg on a U-100 insulin syringe. 20 Units (clicks) equals to 2mg Retatrutide.
• Storage: Lyophilized: After reconstitution, refrigerate at 2–8 °C.

Technical Specifications:

Synonyms: LY3437943
Chemical Formula: C₂₄H₃₄Cl₂N₆O₄
CAS Number: 2381089-83-2
Molecular Weight: Approx. 5,534 g/mol
Purity: ≥99.0% (validated by Certificate of Analysis)
Appearance: White to off-white lyophilized powder
Peptide Length: 39 amino acids
Solubility: Fully soluble in water (H₂O)
Quality Verification: Confirmed by RP-HPLC analysis
Storage Conditions: Store dry at 2–8 °C; reconstituted material refrigerated and used within 6 weeks

Research Use Only: Not for human or veterinary use.